Tissue Transglutaminase: A Novel Therapeutic Target in Cerebral Amyloid Angiopathy

Blockade of enzyme activity inhibits tissue transglutaminase-mediated transamidation of α-synuclein in a cellular model of Parkinson's disease

(2011) Robin Verhaar et al.   NEUROCHEMISTRY INTERNATIONAL

Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy

(2009) Roy O. Weller et al.   ACTA NEUROPATHOLOGICA

Transglutaminases and Transglutaminase-Catalyzed Cross-Links Colocalize with the Pathological Lesions in Alzheimer's Disease Brain

(2008) Micha M.M. Wilhelmus et al.   BRAIN PATHOLOGY

Tissue transglutaminase: A novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases

(2008) Micha M.M. Wilhelmus et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Fibronectin-Tissue Transglutaminase Matrix Rescues RGD-impaired Cell Adhesion through Syndecan-4 and β1Integrin Co-signaling

(2008) Dilek Telci et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Transglutaminase Induces Protofibril-like Amyloid β-Protein Assemblies That Are Protease-resistant and Inhibit Long-term Potentiation

(2008) Dean M. Hartley et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Transglutaminases in Vascular Biology: Relevance for Vascular Remodeling and Atherosclerosis

(2008) Erik N.T.P. Bakker et al.   JOURNAL OF VASCULAR RESEARCH

Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology

(2008) R. O. Carare et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY